Veterinary Medicines

Vetrimoxin L.A. 150 mg/ml suspension for injection for cattle and pigs

Authorised
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Vetrimoxin L.A. 150 mg/ml suspension for injection for cattle and pigs
Vetrimoxin L.A. 150 mg/ml stungulyf, dreifa fyrir nautgripi og svín
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    172.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        3
        day
      • Meat and offal
        18
        day
    • Pig
      • Meat and offal
        16
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Iceland
Available in:
  • Iceland
Package description:
  • (ID4) 3000 millilitre(s): unspecified outer container with 12 Vial (Plastic) each with 250 millilitre(s)
  • (ID3) 250 millilitre(s): unspecified outer container with 1 Vial (Plastic) with 250 millilitre(s)
  • (ID2) 100 millilitre(s): unspecified outer container with 1 Vial (Plastic) with 100 millilitre(s)
  • (ID1) 1200 millilitre(s): unspecified outer container with 12 Vial (Plastic) each with 100 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • CEVA Santé Animale
Responsible authority:
  • Icelandic Medicines Agency
Authorisation number:
  • IS/2/12/012/01
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0153/001
Concerned member states:
  • Austria
  • Denmark
  • Finland
  • Iceland
  • Ireland
  • Netherlands
  • Sweden
  • United Kingdom (Northern Ireland)